Send this to a friend

Boston Scientific artery device caught up in FDA review

The U.S. Food & Drug Administration is conducting a review of balloons and stents using a common chemotherapy drug after a trial found the devices, including one made by Boston Scientific, could actually be harmful.
In January, the FDA wrote healthcare providers about a recent meta-analysis of randomized trial published in December in the Journal of the American Heart Association (JAHA) suggesting a possible increased mortality rate after two y ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media